News
1.0K views | +0 today
Follow
 
Rescooped by Pategou Joseph from Health Care Social Media And Digital Health
onto News
Scoop.it!

Designing With The Patient in Mind

Designing With The Patient in Mind | News | Scoop.it
Marie Ennis-O'Conner explains how the potential of digital technology will never be realized if unless the stakeholders work alongside patients in co-designing

Via Patient Empowerment Network, Marie Ennis-O'Connor
more...
No comment yet.
Your new post is loading...
Your new post is loading...
Scooped by Pategou Joseph
Scoop.it!

#mHealth and #DigitalMasters : #Novartis Vs Kodak

During years, pharma companies have been trying to bring more value to patients and physicians by using mHealth. In this study we observed the consequences of …
more...
No comment yet.
Rescooped by Pategou Joseph from News
Scoop.it!

#Originators and #Princeps: How to face #Biosimilars and #Generics

Concerning the levers a originators producer can put in place to face the biosimilars competition and maintain his position, benchmarking on biosimilars, gener…

Via Pategou Joseph
more...
No comment yet.
Rescooped by Pategou Joseph from News
Scoop.it!

#mHealth and #DigitalMasters : #Novartis Vs Kodak

During years, pharma companies have been trying to bring more value to patients and physicians by using mHealth. In this study we observed the consequences of …
more...
No comment yet.
Rescooped by Pategou Joseph from HEALTHCARE & SOCIAL MEDIA
Scoop.it!

Twitter: The Future of Clinical Trial Recruitment

Twitter: The Future of Clinical Trial Recruitment | News | Scoop.it
The views expressed in this post are mine and mine alone and do not necessarily reflect those of any of my current or past employers. I recently wrote abou

Via Marie Ennis-O'Connor, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
Scoop.it!

Diabeo : la première application remboursée par l’Assurance Maladie 

Diabeo : la première application remboursée par l’Assurance Maladie  | News | Scoop.it
Diabeo : la première application remboursée par l’Assurance Maladie Une application de santé dédiée aux patients diabétiques va être remboursée par la Sécu

Via Bruno Demay, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from Buzz e-sante
Scoop.it!

E-santé : préparez-vous à vivre plus longtemps

E-santé : préparez-vous à vivre plus longtemps | News | Scoop.it
Analyse génomique, téléconsultation ou encore médecine prédictive, le monde médical est en plein bouleversement. Comment la technologi

Via MyPharmag, Rémy TESTON
more...
No comment yet.
Rescooped by Pategou Joseph from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

Google et Levis se lancent dans la veste connectée pour 2017. #hcsmeufr

Google et Levis se lancent dans la veste connectée pour 2017. #hcsmeufr | News | Scoop.it
Google et Levis vont commercialiser une veste connectée. Et elle pourrait intéresser les non-geek.

Via LEO INNOVATION LAB FRANCE, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from PHARMA NEWS, MULTICHANNEL & CROSSCHANNEL MAKETING
Scoop.it!

Étude : les KPIs utilisés pour mesurer le content marketing

Étude : les KPIs utilisés pour mesurer le content marketing | News | Scoop.it
La mesure des KPIs dans le marketing, et plus particulièrement dans le marketing de contenu est souvent sujet à débat. Une étude européenne de HubSpot et S

Via Dix-Katre, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from Santé-pharma : digital, mobile & réseaux sociaux
Scoop.it!

Doctors can tweet and Facebook... but they need to be careful - say new guidelines - #hcsmeufr

Doctors can tweet and Facebook... but they need to be careful - say new guidelines - #hcsmeufr | News | Scoop.it
Irish doctors are free to be on social media sites like Twitter and Facebook- but they need to be careful of what they say.

Via Isabelle Delignière-Léglise
more...
No comment yet.
Rescooped by Pategou Joseph from Santé-pharma : digital, mobile & réseaux sociaux
Scoop.it!

10 Ways for Healthcare Professionals to Stay Compliant on Social Media - #socpharm #hcsmeufr

10 Ways for Healthcare Professionals to Stay Compliant on Social Media - #socpharm #hcsmeufr | News | Scoop.it
As part of a highly regulated industry, many healthcare organizations have been hesitant to adopt social media. But social media is a powerful and authentic communication tool with a unique role to play in health – it helps providers communicate with patients and other physicians, as well as elevates their practices’ public profiles. How is... Read more

Via Isabelle Delignière-Léglise
more...
No comment yet.
Rescooped by Pategou Joseph from Santé-pharma : digital, mobile & réseaux sociaux
Scoop.it!

How social media is shaking up healthcare #socpharm #hcsmeufr

How social media is shaking up healthcare #socpharm #hcsmeufr | News | Scoop.it
A look at the interaction between social media and the healthcare industry.

Via Isabelle Delignière-Léglise
more...
No comment yet.
Rescooped by Pategou Joseph from #ESanté by Umanlife
Scoop.it!

Les allergies alimentaires de demain, e-sante.fr

Les allergies alimentaires de demain, e-sante.fr | News | Scoop.it
Les allergies alimentaires augmentent et évoluent au fil du temps. Quels sont les aliments potentiellement « à risque » à surveiller dans les années à venir ? Le point sur ces allergies émergentes…

Via umanlife
more...
umanlife's curator insight, May 23, 3:50 AM

Les allergies alimentaires de demain, e-sante.fr

Rescooped by Pategou Joseph from Buzz e-sante
Scoop.it!

Cancer : des conseils dépistage en 2 clics par l’INCa

Cancer : des conseils dépistage en 2 clics par l’INCa | News | Scoop.it
L’Institut national du cancer (INCa) lance un nouveau service en ligne pour aider au dépistage des cancers.

Via Rémy TESTON
more...
No comment yet.
Rescooped by Pategou Joseph from News
Scoop.it!

#Originators and #Princeps: How to face #Biosimilars and #Generics

Concerning the levers a originators producer can put in place to face the biosimilars competition and maintain his position, benchmarking on biosimilars, gener…

Via Pategou Joseph
more...
No comment yet.
Rescooped by Pategou Joseph from News
Scoop.it!

BIOSIMILARS - Regulation and Market Trends

Nowadays patients and physicians can have access to three types of drugs: a originators, a generic or a biosimilar. Those drugs have different regulatory syste…

Via Pategou Joseph
more...
No comment yet.
Rescooped by Pategou Joseph from 7- DATA, DATA,& MORE DATA IN HEALTHCARE by PHARMAGEEK
Scoop.it!

IBM Watson being used in real time for @Point of Care’s suite of medical apps

IBM Watson being used in real time for @Point of Care’s suite of medical apps | News | Scoop.it
@Point Care founded by current Chief Executive Officer Robert Stern and Chief Medical Information Officer Sandeep Pulim, MD is composed of a team of healthcare professionals and developers. Their goal was to use their knowledge to build a platform that could not only provide clinical knowledge support but also allow patients to share their data with clinicians. Dr. Sandeep Pulim, CMIO, at @Point of Care took the time to give us a little background about the platform as well as explain how it can be beneficial to both health professionals and patients.

According to Dr. Pulim, @Point of Care, which evolved out of the parent company Products in Knowledge, set out to take advantage of the way clinicians as well as patients were evolving and using technology. He discussed the goal of bridging the gap and coming up with a platform where both clinical professionals and patients could interact. The result is a platform that clinical professionals can not only utilize as a decision-making tool but also use to track patients’ symptoms as well as relay valuable information.

Unlike similar clinical decision support apps, @Point of Care uses real-time patient-generated data and provides clinicians with a chance to earn CME or Continuing Medical Education credits. The @Point of Care platform produces medical apps developed by medical faculty experts and editorial teams to produce disease-specific content that not only provide up to date information but are also certified for CME credits. Within each section of the platform is an activity where clinicians can answer questions and perform other activities and earn credits as they go along.

The platform allows healthcare professionals to do things such as search for certain diseases, access drug databases as well as keep up with patient data. IBM’s Watson technology was used to help collect the data and make utilization easier. The patient data that is collected is readily available to the health professionals as well as the patient to enable shared decision-making at the point of care. The Watson technology helps to make the entire process more efficient and allows the content to be utilized daily. IBM Watson’s cognitive discovery engine allows the platform to quickly access relevant and evidence-based disease-specific medical content. Helping to ensure that users not only find the answers or information they need, they also find the best and most up-to-date info available.

Via Dominique Godefroy, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from WEARABLES - INSIDABLES - IOT - CONNECTED DEVICES - QUANTIFIEDSELF
Scoop.it!

Weaknesses in Medical Device - e.g., Essure - Approvals by #FDA

Weaknesses in Medical Device - e.g., Essure - Approvals by #FDA | News | Scoop.it

There have been thousands of reported adverse events tied to the Essure permanent birth control implant. Now, researchers are looking at how gynecologic devices like Essure are regulated and approved in the first place.

 

Recent controversies surrounding obstetrics and gynecology devices, including a permanent sterilization device, pelvic meshes, and laparoscopic morcellators, highlight the need for deeper understanding of obstetrics and gynecology medical device regulation.

 

The U.S. Food and Drug Administration premarket approval database was queried for approvals assigned to the obstetrics and gynecology advisory committee from January 2000 to December 2015.

 

Eighteen device approvals occurred in the time period studied. The most common clinical indications included endometrial ablation (33%), contraception (28%), and fetal monitoring (17%). The median approval time was 290 days (range 178-1,399 days).

 

Regarding the pivotal trials leading to approval, there were 11 randomized controlled trials, one randomized crossover study, five nonrandomized prospective studies, and two human factor studies. Fourteen devices (78%) met their primary clinical efficacy endpoint. Only 12 of 18 devices were required to conduct postmarket surveillance. A significant proportion of devices (42%) were approved on the basis of nonrandomized controlled trials.

 

Three devices have been withdrawn after approval, all of which were either not referred or not recommended for approval by the obstetrics and gynecology advisory committee. Of the three devices withdrawn from the market, two failed to demonstrate clinical benefit in their pivotal trials. One device was not required to undergo postmarketing surveillance and was subsequently withdrawn as a result of patient safety concerns.

 

Our results reveal significant weaknesses in the preapproval and postapproval regulation of high-risk obstetrics and gynecology devices. Greater specialty group involvement is necessary to ensure the development of safe and clinically effective devices.


Via Pharma Guy, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

Tim Cook hints at greater health features for Apple Watch

Tim Cook hints at greater health features for Apple Watch | News | Scoop.it
Tim Cook has hinted that the Apple Watch will get even greater at monitoring your health and fitness. Speaking at Startup Fest Europe in Amsterdam today, the Apple CEO said the company’s wearable may one day tell you when it’s time for a checkup.Your Apple Watch already wants you to keep fit. It reminds you when it’s time to stand, it sets exercise goals you can work towards each day, and it tracks all kinds of data that lets you keep an eye on your progress. But it could do more.
Via Alex Butler, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from PHARMACY, PHARMACIST, RETAIL - PHARMACIE, PHARMACIEN, DISTRIBUTION
Scoop.it!

Les patients, initiateurs d'un modèle de dispensation innovant ?

Les patients, initiateurs d'un modèle de dispensation innovant ? | News | Scoop.it
La dispensation à l'unité plébiscitée par les patients, serait-elle l'avenir d'un modèle innovant de dispensation des médicaments en pharmacie ?
Via Pharmacomptoir / Corinne Thuderoz, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from GAFAMS, STARTUPS & INNOVATION IN HEALTHCARE by PHARMAGEEK
Scoop.it!

Esanté : les GAFA ont-elles une chance face aux startups ? 

Esanté : les GAFA ont-elles une chance face aux startups ?  | News | Scoop.it
Cela fait maintenant quelques années que j’observe de près l’évolution du monde de la technologie et son impact sur nos vies quotidiennes…

Via DIRECT MEDICA, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by Pategou Joseph from #EventsEsanté Umanlife
Scoop.it!

Tabagisme : le paquet neutre arrive dans les bureaux de tabac

Tabagisme : le paquet neutre arrive dans les bureaux de tabac | News | Scoop.it
Mesure phare de la loi Santé, les paquets neutres peuvent être vendus en France à partir du vendredi 20 mai 2016.

Via umanlife
more...
umanlife's curator insight, May 23, 3:36 AM

Le paquet neutre arrive. Vous pouvez également contrôler votre consommation de tabac sur fr.umanlife.com

Rescooped by Pategou Joseph from All about Pharma by Pharmacomptoir
Scoop.it!

"Le prix des médicaments innovants menace-t-il l'accès aux soins ?"

"Le prix des médicaments innovants menace-t-il l'accès aux soins ?" | News | Scoop.it
Lundi 20 juin 2016, à 9h00 à Paris Assemblée interassociative"Le prix des médicaments innovants menace-t-il l'accès aux soins ?" La question du prix des médicaments innovants suscite une mobilisation sans précédent. en lire plus
Via Giovanna Marsico, Pharmacomptoir / Corinne Thuderoz
more...
No comment yet.
Rescooped by Pategou Joseph from "Patient empowerment and pharma companies | Patient-centricity | Patient-focused drug development | Precision medicine" by VAB Traductions
Scoop.it!

Why you should consider a career in pharma

Why you should consider a career in pharma | News | Scoop.it
KEY TAKEAWAY: Pharma companies need people who can bring an empathetic view to everything they do.  You will have the opportunity to help people with health problems so that they can live a better quality of life. It’s not going to be easy, but when you succeed, you will feel like you made a difference and to me that’s what a career should be about.

Via VAB Traductions
more...
No comment yet.
Rescooped by Pategou Joseph from E-santé, Objets connectés, Telemedecine, Msanté
Scoop.it!

Leaders from the pharma industry explain how they are making an effort to put patients at the centre.

Leaders from the pharma industry explain how they are making an effort to put patients at the centre. | News | Scoop.it
Andrew Schorr introduces a video where leaders from the pharma industry explain at Eyeforpharma Barcelona 2016 how they are making an effort to put patients in the center of their interest. We interviewed Patient executives from Janssen, Sanofi, AbbVie, Teva, UCB and Novartis.

Via Stephen Dunn, eMedToday, Lionel Reichardt / le Pharmageek, Bruno Demay
more...
No comment yet.
Rescooped by Pategou Joseph from "Patient empowerment and pharma companies | Patient-centricity | Patient-focused drug development | Precision medicine" by VAB Traductions
Scoop.it!

Using social data to see patients more clearly - PMLiVE

Using social data to see patients more clearly - PMLiVE | News | Scoop.it
Since the turn of the 21st century, the rise of the social web has brought about phenomenal changes - and opportunities - in the healthcare world. Online platforms have empowered patients to take an active role in their own treatment and allowed them to express themselves more frankly than they might in the presence of a physician. Simultaneously, providers and pharmaceutical companies alike have embraced healthcare consumerism and the tenets of patient-centred care.
Over the course of this tectonic shift, Treato has capitalised on the development of big data analytics to capture the unfiltered 'patient voice'. To date we have collected, organised and analysed more than 2.3 billion user-generated, health-related posts from forums, blogs and social media sites. Pharma companies and healthcare organisations can utilise this data for strategy development, competitive research and patient segmentation, among other applications.
One of the many areas in which social data is employable is in the identification and assessment of adverse drug reactions (ADRs), events which lead to thousands of hospitalisations and deaths each year. What remains unclear, however, is how social data analytics compare in terms of reliability to more established processes for clinical data collection.
To answer this question, we partnered with researchers at Brigham and Women's Hospital, Harvard Medical School, and Partners HealthCare System to conduct a pilot study on the differences and similarities between ADRs stored in electronic health records (EHRs) and concerns shared by patients on social media. Published in Drug Safety, the journal of the International Society of Pharmacovigilance, the study emphasises the growing role social data will play in personalising care and impacting health outcomes.

Via VAB Traductions
more...
No comment yet.
Rescooped by Pategou Joseph from Health Care Social Media And Digital Health
Scoop.it!

Social Media for the Plastic Surgery Resident and How to Get Started

Social Media for the Plastic Surgery Resident and How to Get Started | News | Scoop.it
by M. Shuja Shafqat, MD Social media has exploded in popularity in the last decade, with millions of people regularly using one or more services on a daily basis. Most of us use these websites or apps for recreational purposes. Increasingly businesses, personalities, and doctors have been using them for advertising. Specifically the focus has…

Via Marie Ennis-O'Connor
more...
No comment yet.